🔥🐔 BizChicken 🐔🔥
Companies Similar to Elevation Oncology, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
AnaptysBio, Inc.
Imsidolimab, Rosnilimab, ANB032
Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.
Symbol: ANAB
Recent Price: $13.22
Industry: Biotechnology
CEO: Mr. Daniel R. Faga
Sector: Healthcare
Employees: 117
Address: 10770 Wateridge Circle, San Diego, CA 92121-5801
Phone: 858 362 6295
Last updated: 2024-12-31
CERo Therapeutics Holdings, Inc.
Engineered T Cell Therapeutics
CERo Therapeutics Holdings, Inc. is an immunotherapy company focused on developing engineered T cell therapeutics for cancer treatment, particularly targeting hematologic malignancies using innovative immune system integration strategies.
Symbol: CERO
Recent Price: $0.06
Industry: Biotechnology
CEO: Mr. Christopher B. Ehrlich M.B.A.
Sector: Healthcare
Employees: 8
Address: 201 Haskins Way, South San Francisco, CA 94080
Phone: 650-407-2376
Last updated: 2024-12-31
Elicio Therapeutics, Inc.
ELI-002
Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for cancer and other diseases, with its lead product ELI-002 targeting KRAS-driven cancers.
Symbol: ELTX
Recent Price: $5.00
Industry: Biotechnology
CEO: Mr. Robert T. Connelly
Sector: Healthcare
Employees: 32
Address: 451 D Street, Boston, MA 02210
Phone: 857-209-0050
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Checkpoint Therapeutics, Inc.
Cosibelimab
Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on acquiring, developing, and commercializing novel treatments for solid tumor cancers. Their lead product candidates include Cosibelimab, a fully-human monoclonal antibody, and other treatments for various cancer targets.
Symbol: CKPT
Recent Price: $3.35
Industry: Biotechnology
CEO: Mr. James F. Oliviero III, C.F.A.
Sector: Healthcare
Employees: 23
Address: 95 Sawyer Road, Waltham, MA 02453
Phone: 781 652 4500
Last updated: 2024-12-31
Celldex Therapeutics, Inc.
therapeutic monoclonal and bispecific antibodies
Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies for treating inflammatory diseases and cancers.
About | About | Management | Directors | About | Contact | About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About
Symbol: CLDX
Recent Price: $25.12
Industry: Biotechnology
CEO: Mr. Anthony S. Marucci M.B.A.
Sector: Healthcare
Employees: 160
Address: Perryville III Building, Hampton, NJ 08827
Phone: 908 200 7500
Leadership
- Anthony S. Marucci, Founder, President, Chief Executive Officer and Director
- Tibor Keler, Ph.D., Founder, Executive Vice President and Chief Scientific Officer
- Diane C. Young, M.D., Senior Vice President and Chief Medical Officer
- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer
- Sam Martin, Senior Vice President and Chief Financial Officer
- Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer
- Richard Wright, Ph.D., Senior Vice President and Chief Commercial Officer
- Sarah Cavanaugh, Senior Vice President, Corporate Affairs and Administration
- Margo Heath-Chiozzi, M.D., Senior Vice President, Regulatory Affairs
- Freddy A. Jimenez, Esq., Senior Vice President and General Counsel
- Karen L. Shoos, J.D., Former Chair, Director of Operations, Maryland Tech Council Venture Mentoring Services Program
- Keith L. Brownlie, Former Partner, Ernst & Young LLP
- Herbert J. Conrad, Former President, Roche Pharmaceuticals US
- James J. Marino, J.D., Former Partner, Dechert LLP
- Harry H. Penner, Jr., J.D., L.L.M., Former Chairman and CEO, Nascent Bioscience
- Cheryl L. Cohen, President, CLC Consulting; Former Chief Commercial Officer of Medivation, Inc.
- Dr. Garry Neil, Chief Executive Officer; Chair of the Board, Avalo Therapeutics
- Rita Jain, M.D., Former Executive Vice President, Chief Medical Officer of ChemoCentryx, Inc.
- Carl June, M.D.,
- Michel Nussenzweig, M.D., Ph.D.,
- Marc E. Rothenberg M.D., Ph.D.,
- Joseph Schlessinger, Ph.D.,
- Louis Weiner, M.D.,
Last updated: 2024-12-31
Cardiff Oncology, Inc.
Onvansertib
Cardiff Oncology, Inc. is a clinical-stage oncology company developing treatment medicine for cancer patients, featuring lead drug candidate onvansertib, targeting various cancers including colorectal cancer. The company is headquartered in San Diego, California.
Symbol: CRDF
Recent Price: $4.26
Industry: Biotechnology
CEO: Dr. Mark Erlander Ph.D.
Sector: Healthcare
Employees: 31
Address: 11055 Flintkote Avenue, San Diego, CA 92121
Phone: 858 952 7570
Last updated: 2024-12-31
Curis, Inc.
Emavusertib
Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.
About | Management | Directors | About | About | Contact | Contact | Contact | About | Careers | Careers | Benefits | About | About | About | About | Jobs | About
Symbol: CRIS
Recent Price: $3.14
Industry: Biotechnology
CEO: Mr. James E. Dentzer
Sector: Healthcare
Employees: 49
Address: Building C, Lexington, MA 02421
Phone: 617 503 6500
Leadership
- Martyn D. Greenacre, Chair of the Board
- John Hohneker, M.D., Director
- Kenneth I. Kaitin, Ph.D., Director
- Anne E. Borgman, M.D., Director
- Marc Rubin, M.D., Director
- James Dentzer, Chief Executive Officer and Director
Last updated: 2024-12-31
eFFECTOR Therapeutics, Inc.
Tomivosertib
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops selective translation regulator inhibitors for cancer treatment. Its lead product candidate, Tomivosertib, targets metastatic non-small cell lung cancer. The company also has a collaboration with Pfizer Inc. and develops another candidate, Zotatifin, for solid tumors.
Symbol: EFTR
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 14
Address: 142 North Cedros Avenue, Solana Beach, CA 92075
Phone: 858 925 8215
Last updated: 2024-12-31
Elevation Oncology, Inc.
seribantumab
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for the treatment of cancer in genomically defined patient populations. Their lead program is seribantumab, an anti-HER3 monoclonal antibody for advanced solid tumors.
Symbol: ELEV
Recent Price: $0.57
Industry: Biotechnology
CEO: Mr. Joseph J. Ferra Jr.
Sector: Healthcare
Employees: 29
Address: 888 Seventh Avenue, New York, NY 10106
Phone: 716 371 1125
Last updated: 2024-12-31
Erasca, Inc.
ERAS-007, ERAS-601, ERAS-801
Erasca, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
News | About | About | Careers | Careers | About | Careers | About | About | About | About | About
Symbol: ERAS
Recent Price: $2.55
Industry: Biotechnology
CEO: Dr. Jonathan E. Lim M.D.
Sector: Healthcare
Employees: 126
Address: 10835 Road to the Cure, San Diego, CA 92121
Phone: 858 465 6511
Last updated: 2024-12-31
Immunovant, Inc.
batoclimab
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases, including batoclimab for myasthenia gravis and thyroid eye disease.
Symbol: IMVT
Recent Price: $23.88
Industry: Biotechnology
CEO: Dr. Peter Salzmann M.B.A., M.D.
Sector: Healthcare
Employees: 207
Address: 320 West 37th Street, New York, NY 10018
Phone: 917 580 3099
Leadership
- Pete Salzmann, M.D., MBA, Chief Executive Officer
- Renee Barnett, MBA, Chief Financial Officer
- Christine Blodgett, Senior Vice President of Human Resources
- Andy Deig, Senior Vice President Strategic Finance
- Michael Geffner M.D., MBA, Chief Medical Officer
- Julie Kirschling, Senior Vice President, Program and Alliance Management
- Mark Levine, Chief Legal Officer and Corporate Secretary
- Bill Macias, M.D., Ph.D., Chief Medical Officer
- Becky Merlina, Senior Vice President, Global Head of Quality
- Jody Roth, MS, RAC, PMP, Senior Vice President, Regulatory Affairs
- Jay S. Stout, PhD, Chief Technology Officer
- Yan Zheng, Ph.D., Senior Vice President Biostatistics, Programming & Data Management
- Chandra Adams, Vice President, Associate General Counsel
- Maria Alba, M.D., Vice President of Clinical Development
- Farah Ali, Vice President, Clinical Development
- Jennifer Ashley, Vice President, Associate General Counsel
- Annetta Beauregard, Vice President, Regulatory Affairs Strategy
- Harry Berlanga, MSc., VP, CMC & Distribution Quality
- Ranjit Deshmukh, Ph.D., Vice President of CMC and Technical Operations
- Scott Forman, MBA, Vice President, Program Management
- Tom Forman, MBA, Vice President, CMC Project Management
- Ian Gourley, M.D., Vice President of Clinical Development
- Thomas Hardy, M.D., Ph.D., Vice President of Drug Safety and Pharmacovigilance
- Laci Hasenour, Vice President Marketing, Neurology
- Aileen Ilaria, MBA, Vice President, Clinical Operations – Global Site Management
- Claudia Jacobs, Ph.D., Vice President of CMC Project Management Operations and Clinical Supply
- Jonathan Janes, MB, Vice President Clinical Development
- Ant Kidwell, Vice President of IT and Facilities
- Chedvi Levin-Sister, Vice President of Finance
- Launi Masterson, Vice President of Clinical Operations
- Andy Minke, Vice President Program Management
- Linda McKerral, Vice President, CMC Analytical Sciences
- Pooja Mehta, Vice President Drug Substance Tech Transfer
- Regina Mirra, VP, Regulatory Operational Excellence
- Jennifer Moseley, Vice President of Clinical Operations
- Sheetal Patel M.D., MS MBA, Vice President of Clinical Development
- Cassandra Pauyo, Vice President, Data Management
- Rod Saponjic Ph.D., MBA, Vice President of Clinical Operations
- Lauren Schrier, MBA, Vice President of Marketing
- Frank Torti, M.D., Chairperson of Board of Directors
- Andrew Fromkin, Member of Board of Directors
- Douglas Hughes, Member of Board of Directors
- George Migausky, Member of Board of Directors
- Atul Pande, M.D., Member of Board of Directors
- Eric Venker, M.D., Pharm.D., Member of Board of Directors
Last updated: 2024-12-31
Kura Oncology, Inc.
ziftomenib and tipifarnib
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company developing small molecule medicines for the treatment of cancer. It focuses on genetically defined subsets of acute leukemias and has a collaboration with Novartis for certain carcinoma treatments.
Symbol: KURA
Recent Price: $8.51
Industry: Biotechnology
CEO: Dr. Troy Edward Wilson J.D., Ph.D.
Sector: Healthcare
Employees: 142
Address: 12730 High Bluff Drive, San Diego, CA 92130
Phone: 858 500 8800
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Xencor, Inc.
Monoclonal Antibody and Cytokine Therapeutics
Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.
About | ESG | Contact | Careers | Careers | About | Events | About | About | About | Contact | Management | About | Directors | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers
Symbol: XNCR
Recent Price: $23.71
Industry: Biotechnology
CEO: Dr. Bassil I. Dahiyat Ph.D.
Sector: Healthcare
Employees: 280
Address: 111 West Lemon Avenue, Monrovia, CA 91016
Phone: 626 305 5900
Last updated: 2024-12-31
Y-mAbs Therapeutics, Inc.
DANYELZA
Y-m Abs Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapeutic products for cancer treatment in the United States.
Symbol: YMAB
Recent Price: $7.76
Industry: Biotechnology
CEO: Mr. Michael Rossi
Sector: Healthcare
Employees: 100
Address: 230 Park Avenue, New York, NY 10169
Phone: 646 885 8505
Leadership
- Michael Rossi, President and Chief Executive Officer
- Thomas Gad, Founder, Vice Chairman of the Board of Directors, Chief Business Officer
- Torben Lund-Hansen, SVP, Chief Technical Officer
- Peter Pfreundschuh, Chief Financial Officer
- Vignesh Rajah, SVP, Chief Medical Officer
- Joris Wilms, SVP, Chief Operating Officer
- Sue Smith, SVP, Chief Commercial Officer
- Norman LaFrance, Chief Development Officer
- Johan Wedell-Wedellsborg, Chairman
- Ashutosh Tyagi, M.D.,
- James I. Healy, Chairman
- David N. Gill,
- Laura J. Hamill,
- Mary Tagliaferri, M.D.,
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
The Oncology Institute, Inc.
Medical Oncology Services
An oncology company providing medical oncology services in the United States, including clinical trials, radiation, outpatient stem cell transplants, and patient support, serving adult and senior cancer patients with 67 clinic locations.
About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: TOI
Recent Price: $0.32
Industry: Medical - Care Facilities
CEO: Dr. Daniel Virnich FACHE, M.B.A., M.D.
Sector: Healthcare
Employees: 800
Address: 18000 Studebaker Road, Cerritos, CA 90703
Phone: 213 760 1328
Last updated: 2024-12-31